赛里斯治疗 MCRB 深 沪
已收盘 03-27 16:00:00 美东时间
9.02
-0.310
-3.32%
华盛通- 最 高9.60
- 今 开9.28
- 成交量 3.20万股
- 最 低 8.11
- 昨 收 9.33
- 总市值 83.19万
- 52周最高 29.98
- 市盈率 静 --
- 换手率 0.03%
- 52周最低 0.36
- 委 比 54.23%
- 总股本 9.22万
- 历史最高 52.00
- 量 比 0
- 振 幅 15.97%
- 历史最低 0.36
- 每 手 1
- 风险率 5.43%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Earnings Scheduled For March 12, 2026
Companies Reporting Before The Bell • Seres Therapeutics (NASDAQ:MCRB) is likel...
03-12 19:11
Seres Therapeutics Appoints Richard N. Kender As Executive Chair And Interim CEO
Seres Therapeutics, Inc. (NASDAQ:MCRB), (Seres or the Company), a leading live biotherapeutics company, today announced the appointment of Richard N. Kender as Executive Chair and Interim Chief Executive Officer. Mr.
03-03 05:13
Seres Therapeutics Presents Expanded SER-155 Exploratory Biomarker Data at 2025 ASCO Annual Meeting
Seres Therapeutics reports new data on SER-155 demonstrating its potential to promote T-cell recovery, reduce bloodstream infections, and improve outcomes after allo-HSCT.
2025-05-27 11:00
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers Cardio Diagnostics Hldgs (NASDAQ:CDIO) stock increased by 16.8% to $0....
2024-09-27 04:31
Seres Therapeutics Stockholders Approve Sale Of VOWST To Nestlé Health Science; Sale Expected To Close on September 30
Seres Therapeutics, Inc. (NASDAQ:MCRB), ("Seres" or the "Company"), a leading live biotherapeutics company, today announced that its stockholders voted to approve the previously announced proposed sale of the
2024-09-27 04:03
Canaccord Genuity Maintains Buy on Seres Therapeutics, Maintains $10 Price Target
Canaccord Genuity analyst John Newman maintains Seres Therapeutics (NASDAQ:MCRB) with a Buy and maintains $10 price target.
2024-09-14 02:38
